White papers & guides5 February 2024 eConsent Readiness Guide in 24 Countries eConsent regulations can vary widely across borders. Download this whitepaper to learn the regulatory stances of 24 countries on use of eSignature and eConsent in clinical trials. Learn more
White papers & guides30 March 2023 eConsent Readiness Guide in 18 Countries Author Rafal Zdroik View all posts Learn more
Webinar 3 ways to unlock the value of real-world evidence (RWE) Learn best practices on RWE, Castor’s offerings for collecting RWD, and 3 different RWE case studies from Castor clients Learn more
White papers & guides29 November 2022 2023 Guide to Clinical Data Collection under the EU Medical Device Regulation (EU MDR) Learn key compliance requirements, data collection tips, and important dates for the EU Medical Device Regulation in this white paper. Learn more
Webinar What Patient Experience Can Learn from the 7 Principles of Universal Design Learn why having a good user interface is crucial for enrolling and retaining patients in a decentralized clinical trial Learn more
Webinar SCOPE 2022 | Next-generation clinical data management Join Castor’s own Kimberly Tableman as she discusses clinical data management and how moving away from paper CRFs will improve efficiency Learn more
Webinar The pillars of research in 2035 Join Castor’s Derk Arts and Kimberly Tableman as they discuss what they expect clinical research to look like in 2035 Learn more
White papers & guides27 January 2022 DTx Clinical Trials and Data Standardization In this paper, Castor explores the benefits and challenges of Digital Therapeutics (DTx) trials and provides recommendations on best practices for data collection and management. Learn more
White papers & guides21 January 2022 Choosing Your Best Route to DTx Commercialization In this guide, Castor discusses routes to digital therapeutics commercialization and tools to meet the challenges on the path to market Learn more
White papers & guides18 January 2022 Navigating the DTx Regulatory Landscape The regulations around digital therapeutics (DTx) are constantly changing. Learn how DTx providers are trying to overcome these challenges Learn more